Medicines
Find medicines for human use by name or active substance.
Browse by initial
Medicines beginning with S
641–660 of 1,423 medicines
-
-
-
-
SINEMET CR 25/100mg 100mg/25mg prolonged-release tablets MERCK SHARP DOHME
Active substance: levodopa + carbidopa
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
-
SINEMET CR 50/200mg 200mg/50mg prolonged-release tablets MERCK SHARP DOHME
Active substance: levodopa + carbidopa
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
-
SINERDOL 150mg capsules ANTIBIOTICE
Active substance: rifampicin
J04AB02 Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics
Indicated for: tuberculosis
-
SINERDOL 300mg capsules ANTIBIOTICE
Active substance: rifampicin
J04AB02 Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics
Indicated for: tuberculosis
-
SINERDOL ISO 300mcg/150mcg capsules ANTIBIOTICE
Active substance: rifampicin + isoniazid
Indicated for: bacterial infections
-
SINERDOL ISO 300mg+150mg 300mcg/150mcg capsules ANTIBIOTICE
Active substance: rifampicin + isoniazid
Indicated for: bacterial infections
-
SINERGOLIN 10 10mg sugar-coated tablets SINTOFARM
Active substance: nicergoline
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
Indicated for: cognitive disorders; cerebral circulatory disorders
-
SINERGOLIN 30 30mg sugar-coated tablets SINTOFARM
Active substance: nicergoline
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
Indicated for: cognitive disorders; cerebral circulatory disorders
-
SINERGOLIN 30 30mg sugar-coated tablets SINTOFARM
Active substance: nicergoline
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
Indicated for: cognitive disorders; cerebral circulatory disorders
-
SINFLU 30mg capsules ANTIBIOTICE
Active substance: oseltamivir
J05AH02 Antiinfectives for systemic use | Direct acting antivirals | Neuraminidase inhibitors
Indicated for: influenza
-
SINFLU 75mg capsules ANTIBIOTICE
Active substance: oseltamivir
J05AH02 Antiinfectives for systemic use | Direct acting antivirals | Neuraminidase inhibitors
Indicated for: influenza
-
SINGULAIR 10mg film-coated tablets MERCK SHARP DOHME
Active substance: montelukast
Indicated for: asthma; allergic rhinitis
-
SINGULAIR 4mg chewable tablets MERCK SHARP DOHME
Active substance: montelukast
Indicated for: asthma; allergic rhinitis
-
SINGULAIR 4mg granules MERCK SHARP DOHME
Active substance: montelukast
Indicated for: asthma; allergic rhinitis
-
SINGULAIR 4mg/sachet granules MERCK SHARP DOHME
Active substance: montelukast
Indicated for: asthma; allergic rhinitis
-
SINGULAIR 5mg chewable tablets MERCK SHARP DOHME
Active substance: montelukast
Indicated for: asthma; allergic rhinitis
-
SINOPRYL 10 10mg tablets ANTIBIOTICE
Active substance: lisinopril
C09AA03 Cardiovascular system | Ace inhibitors, plain
Indicated for: hypertension
About medicines
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.